Microfluidic Culture Model of Female Reproductive Tract Built

Share this content:
Microfluidic Culture Model of Female Reproductive Tract Built
Microfluidic Culture Model of Female Reproductive Tract Built

FRIDAY, March 31, 2017 (HealthDay News) -- A microfluidic platform has been developed to model the human reproductive tract and menstrual cycle, according to a report published online March 28 in Nature Communications.

Shuo Xiao, Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues used microfluidics, representing an engineered manipulation of fluid flow in a set of micrometer-sized channels, to create a model of the human reproductive tract and 28-day menstrual cycle. Mouse ovarian tissue was cultured for 28 days in the Solo- and Duet-MFP systems, resulting in follicle production of 28-day menstrual cycle hormone profiles. The ovary, fallopian tube, uterus, cervix, and liver were also cultured using the Quintet-MFP system.

The researchers found that the microfluidic system supported murine ovarian follicles to produce the human 28-day menstrual cycle hormone profile. The female reproductive tract was also simulated in vivo as well as the endocrine loops between organ modules for the ovary, fallopian tube, uterus, cervix, and liver; there was a sustained circulating flow between all tissues.

"The reproductive tract tissues and peripheral organs integrated into a microfluidic platform, termed EVATAR, represents a powerful new in vitro tool that allows organ-organ integration of hormonal signaling as a phenocopy of menstrual cycle and pregnancy-like endocrine loops and has great potential to be used in drug discovery and toxicology studies," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Higher Fish Intake Appears to Reduce RA Symptoms

Higher Fish Intake Appears to Reduce RA Symptoms

Researchers suggest most varieties of fish may play a role in controlling symptoms

Longer Survival for Midostaurin  Chemotherapy in AML With FLT3

Longer Survival for Midostaurin + Chemotherapy in AML ...

Prolonged overall, event-free survival for patients with acute myeloid leukemia, FLT3 mutation

HIV Testing Inadequate in Young Men Who Have Sex With Men

HIV Testing Inadequate in Young Men Who Have ...

Only 28 percent of young MSM have HIV testing, though they account for 83 percent of new diagnoses

is free, fast, and customized just for you!

Already a member?

Sign In Now »